Recombinant Human Thyrotropin Use Resulting in Ovarian Hyperstimulation: An Unusual Side Effect

Publisher： Karger

E-ISSN： 2235-0802|3|2|125-129

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.3, Iss.2, 2014-06, pp. : 125-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer

By  

European Thyroid Journal, Vol. 2, Iss. 3, 2013-09 ,pp. : 195-202

Karger

Access to resources Recommend Favorite

Effects of Recombinant Human Thyrotropin on Heart Rate Variability and Blood Pressure in Patients on l-Thyroxine-Suppressive Therapy for Differentiated Thyroid Carcinoma

By  

Hormone Research in Paediatrics, Vol. 64, Iss. 2, 2005-10 ,pp. : 100-106

Karger

Access to resources Recommend Favorite

Use of Recombinant Human Growth Hormone in Children with Thalassemia

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2009-01 ,pp. : 46-50

Karger

Access to resources Recommend Favorite

Recombinant Human Thyroid-Stimulating Hormone: Use in Papillary and Follicular Thyroid Cancer

By  

Hormone Research in Paediatrics, Vol. 67, Iss. 1, 2007-02 ,pp. : 132-142

Karger

Access to resources Recommend Favorite

Thyrotropin-Releasing Hormone as a Mediator of the Central Autonomic Pathway Controlling Ovarian Function

By  

Neuroendocrinology, Vol. 77, Iss. 4, 2003-05 ,pp. : 273-281

Karger

Access to resources Recommend Favorite